Lipid Metabolism and Ferroptosis in Cancer: Regulatory Mechanisms, Alternative Splicing, and Therapeutic Implications
- 1Department of Medical Biochemistry, “Iuliu-Hațieganu” University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania
- 2Department of Inorganic Chemistry, Faculty of Pharmacy, “Iuliu-Hațieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania
- 3Department of Pharmaceutical Biochemistry and Clinical Laboratory, Faculty of Pharmacy, “Iuliu-Hațieganu” University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania
Abstract
Ferroptosis is an iron-dependent form of regulated cell death driven by phospholipid peroxidation and is increasingly recognized as an important vulnerability in cancer. Its sensitivity is determined by the interplay between membrane lipid composition, iron availability, oxidative stress, and antioxidant defense. Cancer cells can adapt to these pressures by altering the balance between polyunsaturated and monounsaturated fatty acids, thereby shifting toward either ferroptosis sensitivity or resistance. Emerging evidence indicates that alternative splicing provides an additional regulatory layer by generating functionally distinct isoforms of genes involved in cystine transport, iron metabolism, oxidative stress, antioxidant protection, and lipid remodeling. Functionally validated splice events affecting the cystine/glutamate antiporter subunit, transferrin receptor, spermidine/spermine acetyltransferase 1, SCL/TAL1 interrupting locus protein, and cluster of differentiation 44 demonstrate that isoform switching can influence ferroptotic susceptibility independently of total gene expression. This review integrates current knowledge on the biochemical basis of ferroptosis, the lipid determinants of ferroptosis sensitivity, and splicing-dependent mechanisms that shape vulnerability and resistance in cancer. Therapeutic strategies targeting ferroptosis defense systems, lipid metabolism, and alternative splicing are also discussed. Finally, we highlight the potential of integrating long-read ribonucleic acid sequencing, lipidomics, proteomics, and functional ferroptosis assays to develop multidimensional vulnerability signatures for patient stratification and precision cancer therapy.
Related
- Circadian rhythm dysregulation and ferroptosis in hypertension: mechanisms and therapeutic implications
- Epithelial-mesenchymal transition plasticity in breast cancer: regulatory mechanisms and therapeutic implications
- Resveratrol Modulates Bone Metabolism Through SIRT1-Mediated NF-κB Inhibition: Molecular Mechanisms and Therapeutic Implications.
- Targeting tetrahydrobiopterin metabolism in diabetic neuropathic pain: mechanisms, implications, and therapeutic strategies.
- SLC7A11 deficiency exacerbates systemic lupus erythematosus by inducing instability and ferroptosis in regulatory T cells
BibTeX
@article{procopciuc2026lipid,
title = {{Lipid Metabolism and Ferroptosis in Cancer: Regulatory Mechanisms, Alternative Splicing, and Therapeutic Implications}},
author = {Lucia Maria Procopciuc and Adriana Corina Hangan and Roxana Liana Lucaciu},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27209244},
url = {https://www.mdpi.com/1422-0067/27/20/9244},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Lipid Metabolism and Ferroptosis in Cancer: Regulatory Mechanisms, Alternative Splicing, and Therapeutic Implications
AU - Lucia Maria Procopciuc
AU - Adriana Corina Hangan
AU - Roxana Liana Lucaciu
PY - 2026
DA - 2026/10/01
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27209244
UR - https://www.mdpi.com/1422-0067/27/20/9244
AB - Ferroptosis is an iron-dependent form of regulated cell death driven by phospholipid peroxidation and is increasingly recognized as an important vulnerability in cancer. Its sensitivity is determined by the interplay between membrane lipid composition, iron availability, oxidative stress, and antioxidant defense. Cancer cells can adapt to these pressures by altering the balance between polyunsaturated and monounsaturated fatty acids, thereby shifting toward either ferroptosis sensitivity or resistance. Emerging evidence indicates that alternative splicing provides an additional regulatory layer by generating functionally distinct isoforms of genes involved in cystine transport, iron metabolism, oxidative stress, antioxidant protection, and lipid remodeling. Functionally validated splice events affecting the cystine/glutamate antiporter subunit, transferrin receptor, spermidine/spermine acetyltransferase 1, SCL/TAL1 interrupting locus protein, and cluster of differentiation 44 demonstrate that isoform switching can influence ferroptotic susceptibility independently of total gene expression. This review integrates current knowledge on the biochemical basis of ferroptosis, the lipid determinants of ferroptosis sensitivity, and splicing-dependent mechanisms that shape vulnerability and resistance in cancer. Therapeutic strategies targeting ferroptosis defense systems, lipid metabolism, and alternative splicing are also discussed. Finally, we highlight the potential of integrating long-read ribonucleic acid sequencing, lipidomics, proteomics, and functional ferroptosis assays to develop multidimensional vulnerability signatures for patient stratification and precision cancer therapy.
SN - 1422-0067
ER -